
Myrio Tx at BIO Europe Spring
March 31, 2026Myrio Tx was pleased to present at the 2026 SITC Spring Scientific, showcasing our poster,
“Development of a novel T cell engager for small cell lung cancer and other neuroendocrine cancers.”
This year’s meeting brought together global experts across cell therapy, drug development, and IO, with a strong focus on next-generation cellular therapies, T-cell engagers, and innovative combination strategies.
Held March 25–27 in Tucson, the event highlighted the pace of progress and the importance of collaboration in advancing new treatment paradigms for patients.




